Intensity-modulated proton therapy (IMPT) improves overall survival (OS) and reduces high-grade toxicity compared with intensity-modulated radiation ...

Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for ...

According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...

Radiotherapy professionals from 10 Asian countries have completed an IAEA training course on ultra-hypofractionated radiotherapy — a way of treating cancer with ionizing radiation that reduces ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

After undergoing surgery, reconstruction and radiation for breast cancer, the TODAY contributor must have another procedure ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” ...

The relationship between inflammation and cancer represents one of the central paradoxes in modern tumor immunology. On one hand, chronic inflammation is a ...

A cancer diagnosis today is much different than it used to be. Coming up at 9 a.m. on Wednesday, MPR News host Angela Davis ...